Tapewire

Nasdaq · USD

ROIV

Roivant Sciences Ltd.

Export transactions ↓
Tapewire entity
3185
SEC CIK
0001635088
Parsed reports
457

Last 12 months

Inside the activity.

0 purchase rows · 114 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025016
Dec 2025029
Jan 202601
Feb 2026020
Mar 202603
Apr 202603
May 202601
Jun 2026023
Jul 202601
Aug 202609
Sep 202606
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 25, 2022 Filed Mar 29, 2022 22:27 UTC
Kumar RakhiChief Accounting Officer
SaleCommon Shares 7,281 $5.06 $36,841.86
Disclosure

SEC source: 0000899243-22-012699 · doc4.xml · nonDerivative · entry 1

Kumar Rakhi · CIK 0001856296 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,049

F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
March 18, 2022 Filed Mar 23, 2022 01:00 UTC
Kumar RakhiChief Accounting Officer
SaleCommon Shares 2,153 $5.13 $11,044.89
Disclosure

SEC source: 0000899243-22-011864 · doc4.xml · nonDerivative · entry 1

Kumar Rakhi · CIK 0001856296 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,330

F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
March 18, 2022 Filed Mar 23, 2022 01:00 UTC
Gline MatthewDirector · CEO
SaleCommon Shares 82,006 $5.13 $420,690.78
Disclosure

SEC source: 0000899243-22-011863 · doc4.xml · nonDerivative · entry 1

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,507,283

F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
March 07, 2022 Filed Mar 10, 2022 02:45 UTC
Kumar RakhiChief Accounting Officer
SaleCommon Shares 3,091 $5.52 $17,062.32
Disclosure

SEC source: 0000899243-22-010364 · doc4.xml · nonDerivative · entry 1

Kumar Rakhi · CIK 0001856296 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,483

F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4

Read SEC document
March 07, 2022 Filed Mar 10, 2022 02:45 UTC
Gline MatthewDirector · CEO
SaleCommon Shares 92,324 $5.52 $509,628.48
Disclosure

SEC source: 0000899243-22-010363 · doc4.xml · nonDerivative · entry 1

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,589,289

F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
October 20, 2021 Filed Oct 22, 2021 20:07 UTC
Pulik RichardCHIEF FINANCIAL OFFICER
GrantStock Option (Right to Buy) · Derivative 313,419 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0000950103-21-016280 · dp160198_4-pulik.xml · derivative · entry 1

Pulik Richard · CIK 0001885841 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,419

Underlying: Common Shares · 313,419 shares

Expires 2031-10-19

F1 · derivative.exercise_date: Represents an award of stock options ("Options") to purchase Common Shares with a vesting commencement date of September 28, 2021. Award of Options vests and becomes exercisable as follows: (i) 25% on the one-year anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.